SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041240
Filing Date
2019-11-07
Accepted
2019-11-06 20:09:43
Documents
93
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amrx-10q_20190930.htm 10-Q 3956167
2 EX-31.1 amrx-ex311_12.htm EX-31.1 16592
3 EX-31.2 amrx-ex312_10.htm EX-31.2 16646
4 EX-31.3 amrx-ex313_14.htm EX-31.3 16625
5 EX-32.1 amrx-ex321_6.htm EX-32.1 9664
6 EX-32.2 amrx-ex322_11.htm EX-32.2 9606
7 EX-32.3 amrx-ex323_8.htm EX-32.3 9655
  Complete submission text file 0001564590-19-041240.txt   15084722

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT amrx-20190930.xml EX-101.INS 3780140
9 XBRL TAXONOMY EXTENSION SCHEMA amrx-20190930.xsd EX-101.SCH 89485
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE amrx-20190930_cal.xml EX-101.CAL 104276
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amrx-20190930_def.xml EX-101.DEF 367699
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrx-20190930_lab.xml EX-101.LAB 677210
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrx-20190930_pre.xml EX-101.PRE 542861
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38485 | Film No.: 191197802
SIC: 2834 Pharmaceutical Preparations